Multiple Manufacturers

Hemgenix

Manufacturer:

Multiple Manufacturers

Hemgenix HCPCS:

J1411

HCPCS Code Descriptor:

Injection, etranacogene dezaparvovec-drlb, per therapeutic dose

Category:

J Code

Hemgenix NDCs:

0053-0230-23, 0053-0150-15, 0053-0140-14, 0053-0110-11, 0053-0130-13, 0053-0120-12, 0053-0190-19, 0053-0170-17, 0053-0160-16, 0053-0180-18, 0053-0220-22, 0053-0210-21, 0053-0270-27, 0053-0240-24, 0053-0280-28, 0053-0260-26, 0053-0250-25, 0053-0310-31, 0053-0300-30, 0053-0330-33, 0053-0340-34, 0053-0320-32, 0053-0290-29, 0053-0400-40, 0053-0390-39, 0053-0380-38, 0053-0370-37, 0053-0350-35, 0053-0410-41, 0053-0360-36, 0053-0430-43, 0053-0420-42, 0053-0440-44, 0053-0450-45, 0053-0470-47, 0053-0480-48, 00053-0110-11, 00053-0100-10, 00053-0140-14, 00053-0150-15, 00053-0120-12, 00053-0190-19, 00053-0160-16, 00053-0170-17, 00053-0180-18, 00053-0200-20, 00053-0220-22, 00053-0210-21, 00053-0230-23, 00053-0240-24, 00053-0250-25, 00053-0260-26, 00053-0270-27, 00053-0280-28, 00053-0350-35, 00053-0330-33, 00053-0340-34, 00053-0360-36, 00053-0370-37, 00053-0380-38, 00053-0390-39, 00053-0410-41, 00053-0400-40, 00053-0420-42, 00053-0450-45, 00053-0430-43, 00053-0440-44, 00053-0460-46, 00053-0470-47, 00053-0130-13, 00053-0480-48, 00053-0290-29, 00053-0320-32, 00053-0310-31, 00053-0300-30

Primary Type:

Hematology

Generic/Specialty Status:

Multi-Source

Package Type:

Kit

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00053-0110-11, 00053-0100-10, 00053-0140-14, 00053-0150-15, 00053-0120-12, 00053-0190-19, 00053-0160-16, 00053-0170-17, 00053-0180-18, 00053-0200-20, 00053-0220-22, 00053-0210-21, 00053-0230-23, 00053-0240-24, 00053-0250-25, 00053-0260-26, 00053-0270-27, 00053-0280-28, 00053-0350-35, 00053-0330-33, 00053-0340-34, 00053-0360-36, 00053-0370-37, 00053-0380-38, 00053-0390-39, 00053-0410-41, 00053-0400-40, 00053-0420-42, 00053-0450-45, 00053-0430-43, 00053-0440-44, 00053-0460-46, 00053-0470-47, 00053-0130-13, 00053-0480-48, 00053-0290-29, 00053-0320-32, 00053-0310-31, 00053-0300-30

About Hemgenix:

Hemgenix is a medication manufactured by multiple manufacturers and aligned to the J Code: J1411. Hemgenix is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J1411 Added Date:

April 1, 2023

J1411 Effective Date:

April 1, 2023

J1411 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Hemgenix billing and coding information.
Our team did not identify a source for Hemgenix patient assistance information. Please reach out to our team if you feel that this is a mistake.
Hemgenix prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for Hemgenix. Please check back in a few weeks.